Drug Development 2

AI for Drug Discovery, surfaces high-potential drug targets. floatz AI for Drug Discovery helps surface high-potential drug targets grounded in human genetics, expression patterns, and biological pathways, built for translational success. It integrates human genetics, tissue expression, and pathway analysis to map billions of concepts and identify targets with real translational potential, delivering 3 clinically-relevant targets in 14 days.

Unlearn uses AI digital twins to streamline clinical trials and improve decision-making. Unlearn uses AI to create digital twins of clinical trial participants, streamlining clinical development and enabling confident decision-making. Their platform simulates outcomes for every participant at the beginning of a clinical study, predicting every clinical outcome at every future time point with precision. They generate digital twins of patients in studies, delivered through a state-of-the-art, easy-to-use platform that minimizes trial failure, cuts costs, and accelerates timelines.